Physician profile
Logan Leavitt
NPI 1316563489
$1,991.15
in general payments reported to CMS, 2019-2025
9 companies · $883 in 2025
The $883 reported for 2025 was more than what 86% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $204 · 2023: $556 · 2024: $348 · 2025: $883.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,627 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,627.34 |
| Education | $159.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $527.72 | 2023-2025 | Dysport |
| Merz Pharmaceuticals, LLC | $441.05 | 2022-2024 | Xeomin |
| Boston Scientific Corporation | $260.13 | 2025 | Intracept, General - Pain Management |
| Medtronic, INC. | $213.59 | 2023-2025 | Synchromedii, Intellis Adaptivestim |
| Abbvie INC. | $178.91 | 2022-2023 | |
| Stryker Corporation | $159.11 | 2025 | Spinejack, Mild Device Kit |
| Mml US, INC. | $128.15 | 2025 | Reactiv8 |
| Spr Therapeutics, INC | $52.94 | 2025 | Sprint Pns System |
| Nalu Medical, INC. | $29.55 | 2025 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Leavitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.